For example, a 2021 report published in Frontiers in Endocrinology showed that over 3056 weeks, injectable semaglutide reduced A1C numbers by 1.51.8%, while semaglutide tablets reduced them by 1.01.4%
Based on the research available and what I observe in my clinic, I believe the improvements people are experiencing come from overall weight loss and fluid shifts in the body, not because GLP-1s are fixing or healing a damaged lymphatic system
Albrecht et al that federal preemption questions are questions of law, not fact
This is one of the strongest arguments against starting keto and GLP-1 at the same time
But if this is the only data we have, thats what we have to work from
Normality assumption was examined prior to analysis and data were log transformed when appropriate to ensure normality of distribution